Market Overview:
The global perfusion systems market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for organ transplants, technological advancements in perfusion systems, and rising number of hospitals and clinics. Based on type, the global perfusion systems market is segmented into bioreactor and microfluidic. The bioreactor segment is expected to account for the majority share of the global perfusion systems market in 2018. This can be attributed to its ability to support large-scale cell culture operations as well as its growing adoption in regenerative medicine applications. Based on application, the global perfusion systems market is segmented into hospitals and clinics. The hospitals segment accounted for a larger share of the global perfusion systems market in 2017 owing to an increase in organ transplant surgeries across regions such as North America and Europe.
Product Definition:
A perfusion system is a device that circulates blood or other fluids through the body in order to provide nutrients and oxygen to tissues and remove waste products. The importance of perfusion systems is that they are necessary for delivering life-saving treatments such as dialysis and chemotherapy, as well as for performing vital medical procedures such as heart surgery.
Bioreactor:
A bioreactor is a closed system that contains an internal mix of gases or liquids which are separated by a membrane from the external environment. The internal mix can be either liquid or gas based. Bioreactors are used in various industries such as food & beverage, chemical processing, pharmaceuticals and wastewater treatment among others.
Microfluidic:
Microfluidic is a technology that involves the manipulation of liquids on a nanoscale. Microfluidics has emerged as an attractive and versatile solution for various applications in biological, chemical, physical, and biomedical sciences.
Application Insights:
Based on the application, the global market has been segmented into hospitals, clinics and other healthcare facilities and home care. Hospitals dominated this market in 2017 owing to factors such as a large patient base requiring invasive procedures for various diseases along with an increase in government funding for hospital-based treatment. In addition, increasing investments by pharmaceutical companies for R&D pertaining to new drugs is also driving this segment.
Clinics are expected to emerge as the fastest growing application over the forecast period due to increasing demand from countries such as China and India coupled with rising awareness regarding Perfusion Technology among healthcare professionals globally. Increasing cases of chronic kidney disease (CKD) have created a huge demand for percutaneous dialysis machines which necessitates perfusion systems in clinics that perform these procedures thus contributing towards segment growth during the forecast period.
Other applications include home care.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major players and increased adoption of advanced technologies. The region is expected to maintain its dominance over the forecast period due to increasing government funding for R&D activities pertaining perfusion systems and rising incidence of cardiovascular diseases & cancer. Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure, growing medical tourism, increase in per capita income, and demand for organ transplantation procedures.
Moreover, a large number of hospitals are focusing on reducing operating costs by adopting these machines which will drive regional demand further. Furthermore; an increase in awareness regarding new technology usage along with high unmet needs regarding organ transplantation procedures is likely boost regional growth over the next eight years (2030).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) is expected to drive the demand for perfusion systems over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth as this population is more susceptible to CVDs.
- Technological advancements in perfusion systems are projected to fuel the market growth during the forecast period. For instance, introduction of portable and wearable devices has revolutionized the way perfusion therapies are delivered across various settings such as hospitals, clinics, and homecare settings. This is likely to increase their adoption in near future.
- Growing number of clinical trials for novel therapeutics using perfusion systems is another key factor that would propel market growth during forecast period . For instance, In November 2017, Terumo Corporation announced initiation of a phase III clinical trial for its product “TERUMO BCT Perfusor Space” which uses convective-enhanced peritoneal dialysis (CEPD) technology for treatment of patients with end-stage renal disease (ESRD). Such initiatives are expected to create lucrative opportunities for players operating in this market over next few years . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Perfusion Systems Market Research Report
By Type
Bioreactor, Microfluidic
By Application
Hospitals, Clinics
By Companies
Medtronic, Nipro Corporation, Getinge AB, Livanova PLC, Terumo Corporation, Repligen Corporation, Spectrum Laboratories, Merck KGaA, Harvard Bioscience, ALA Scientific Instruments, Medtronic, Xvivo Perfusion
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Perfusion Systems Market Report Segments:
The global Perfusion Systems market is segmented on the basis of:
Types
Bioreactor, Microfluidic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Nipro Corporation
- Getinge AB
- Livanova PLC
- Terumo Corporation
- Repligen Corporation
- Spectrum Laboratories
- Merck KGaA
- Harvard Bioscience
- ALA Scientific Instruments
- Medtronic
- Xvivo Perfusion
Highlights of The Perfusion Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bioreactor
- Microfluidic
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Perfusion Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Perfusion systems are medical devices that help deliver oxygen and other vital nutrients to the body. They can be used in a variety of settings, including hospitals, clinics, and home health care. Perfusion systems are often used in conjunction with other medical devices, such as ventilators and dialysis machines.
Some of the major companies in the perfusion systems market are Medtronic, Nipro Corporation, Getinge AB, Livanova PLC, Terumo Corporation, Repligen Corporation, Spectrum Laboratories, Merck KGaA, Harvard Bioscience, ALA Scientific Instruments, Medtronic, Xvivo Perfusion.
The perfusion systems market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Perfusion Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Perfusion Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Perfusion Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Perfusion Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Perfusion Systems Market Size & Forecast, 2018-2028
4.5.1 Perfusion Systems Market Size and Y-o-Y Growth
4.5.2 Perfusion Systems Market Absolute $ Opportunity
Chapter 5 Global Perfusion Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Perfusion Systems Market Size Forecast by Type
5.2.1 Bioreactor
5.2.2 Microfluidic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Perfusion Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Perfusion Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Perfusion Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Perfusion Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Perfusion Systems Analysis and Forecast
9.1 Introduction
9.2 North America Perfusion Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Perfusion Systems Market Size Forecast by Type
9.6.1 Bioreactor
9.6.2 Microfluidic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Perfusion Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Perfusion Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Perfusion Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Perfusion Systems Market Size Forecast by Type
10.6.1 Bioreactor
10.6.2 Microfluidic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Perfusion Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Perfusion Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Perfusion Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Perfusion Systems Market Size Forecast by Type
11.6.1 Bioreactor
11.6.2 Microfluidic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Perfusion Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Perfusion Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Perfusion Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Perfusion Systems Market Size Forecast by Type
12.6.1 Bioreactor
12.6.2 Microfluidic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Perfusion Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Perfusion Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Perfusion Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Perfusion Systems Market Size Forecast by Type
13.6.1 Bioreactor
13.6.2 Microfluidic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Perfusion Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Perfusion Systems Market: Competitive Dashboard
14.2 Global Perfusion Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Nipro Corporation
14.3.3 Getinge AB
14.3.4 Livanova PLC
14.3.5 Terumo Corporation
14.3.6 Repligen Corporation
14.3.7 Spectrum Laboratories
14.3.8 Merck KGaA
14.3.9 Harvard Bioscience
14.3.10 ALA Scientific Instruments
14.3.11 Medtronic
14.3.12 Xvivo Perfusion
